RESUMEN
【Objective】 To explore and evaluate infection control measures of preventing cross-contamination of novel coronavirus during gastrointestinal endoscopy treatment. 【Methods】 According to the hospital’s infection control requirements and related documents, infection control measures were formulated and implemented by combining with our actual clinical situation, including the management of the endoscope room, management and protection of patients and endoscopists. Then, we evaluated the effect of these measures. 【Results】 From January 25 to March 10, 2020, a total of 71 patients (53 males and 18 females) completed gastrointestinal endoscopy treatment, with an average age of 54 years (28-81 years). There were 36 (50.7%) cases of emergency treatment. All patients had been kept in quarantine for about 14 days (24±13), and no cross-contamination of novel coronavirus occurred. 【Conclusion】 During the novel coronavirus infection epidemic period, reasonable and effective measures should be taken to minimize the risk of infection in doctors and patients. The endoscope center should strengthen preoperative screening and management of patients, master indications of endoscopic procedures, complete endoscopists’ management and protection work, strictly follow the specifications of sterilizing gastrointestinal endoscopes, and construct the layout of "three zones and two passages".
RESUMEN
Objective: To investigate the correlation between gastric acid pH value of patients with acid-related gastric diseases and the score of their life events. Methods: To evaluate the LES (life event scale) of the 108 patients with acid-related diseases were divided into 3 groups according their cluster of gastric acid pH value, group one pH 1.3 (n=37), group two pH 1.6~1.7(n=32), group three pH 2.1~4.5(n=39). Results: The LES total score and factor scores increased with the gastric acid level, the total score of the three groups were 40.0?20.6, 15.1?9.2, 6.4?6.5 respectively, the differences among the three groups were significant (F=43.26,P